Skip to content
naulon

Not checkedNot checked for notices yet.

Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies

Joan Montero, Cécile Gstalder, Daniel J. Kim and 12 more

Nature Communications · 2019

doi:10.1038/s41467-019-12477-y (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

MAPK-targeted therapies fail to achieve complete remission. Here, the authors show that anti-apoptosis resistance is acquired in these targeted therapies through the mRNA destabilization of NOXA which leads to dependence on MCL-1, and that sequential combination of MCL-1 inhibition with targeted therapies overcomes this resistance.

Abstract licence: CC BY-NC-ND

References71

  1. 25.

39 more references, whose wording the paper’s licence keeps private.

All 71 references

Cited by papers we hold1

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.